 |
|
Scientists in U.S. have for the first
time created cloned primate embryos and used them to make embryonic
stem-cell lines, according to the British scientific journal of Nature
published on Wednesday.(File Photo)
|
WASHINGTON, Nov. 14 (Xinhua) -- Scientists in U.S.
have for the first time created cloned primate embryos and used them to make
embryonic stem-cell lines, according to the British scientific journal of Nature
published on Wednesday.
Scientists at Oregon Health & Science
University's Oregon National Primate Research Center reported that they firstly
obtained skin cells from a 9-year-old male rhesus macaque monkey called Semos.
Then they used specialized imaging software called
Oosight Spindle Imaging System, to spot and remove the nuclear material attached
to the spindle fibers of female rhesus monkeys' eggs.
In the end, they inserted the nuclei of skin cells
into nucleus-free eggs, and eventually cloned monkey embryos. Using the embryos,
they successfully developed two embryonic stem cell lines -- groups of cells
that can grow indefinitely and differentiate into any cells of the body.
The genetic material (DNA) of cell lines was then
matched to DNA from the male donor monkey to ensure that they were a direct
clone.
Successful development of the cell lines required
numerous attempts. Overall, 304 monkey eggs from 14 female rhesus monkeys were
used to generate the two stem cell lines, a 0.7 percent success rate, according
to the brief report released Wednesday by the university.
Before publishing the researchers' papers, Nature
took an unusual step of asking another team of researchers to verify the work.
Science community has painful memories when the claim
of a similar breakthrough with human embryos by a South Korean scientist Woo Suk
Hwang in 2004 turned out to be false.
The only other animal in which cloned embryonic stem
cells have been created is mice.
Although the rapid succession of clones after Dolly
the Sheep was announced in 1997 gave confidence to the field of cloning,
continued failure to clone human or monkey embryos led to some pessimism.
Primate-cloning researcher Gerald Schatten stated in
2003, after his study of 716 monkey eggs that failed to produce a clone, that it
might be impossible to do so.
"With current approaches, NT (nuclear transfer, a
cloning technique) to produce embryonic stem cells in non-human primates may
prove difficult -- and reproductive cloning unachievable," said Schatten.
Therefore, today's accomplishment in primates by
Oregon team is "like breaking the sound barrier", says Robert Lanza, with
Advanced Cell Technology in Los Angeles, California.
The team led by Shoukhrat Mitalipov at Oregon Health
and Science University had been trying for nearly a decade to achieve
reproductive cloning in primates, and had used some 15,000 eggs in the process.
After Hwang's results was proved to be fraudulent,
the group decided to move from reproductive cloning to try to establish a cloned
embryonic stem-cell line instead -- theoretically, a more achievable goal.
Last autumn, the researchers had a false start when a
cloned embryo, created by inserting a monkey skin cell into a monkey egg that
had had its DNA removed, produced what seemed to be viable embryonic stem cells.
After a week, they watched in dismay as the cells
started to differentiate uncontrollably, losing their nature as embryonic stem
cells.
But by January 2007, they had another line that
retained its embryonic stem-cell properties, and a couple of months later, they
had created yet another.
These results are outlined in Nature. David Cram, a
researcher from Monash University in Australia, and his colleagues have
independently confirmed the results, according to Nature.
The achievement has led to speculation about when
similar success in humans might open up the door for therapeutic cloning, Nature
said in a news release on Wednesday.
Mitalipov, the lead researcher says that it is still
too early to hope for success in reproductive cloning in monkeys, let alone
humans; the science community is generally against reproductive cloning in
humans.